Schedule 13D Amendment No. 13

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934

(Amendment No. 13)*

 

 

 

Intermec, Inc.

(Name of Issuer)

 

 

 

Common Stock ($0.01 par value)

(Title of Class of Securities)

 

458786100

(CUSIP Number)

 

Scott Renwick

Unitrin, Inc.

One East Wacker Drive

Chicago, Illinois 60601

312-661-4600

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

April 8, 2011

(Date of Event which Requires Filing of This Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box  ¨.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss. 240.13d-7(b) for other parties to whom copies are to be sent.

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 458786100

   SCHEDULE 13D/A   

Page 2 of 6

 

 

  1.   

Name of Reporting Persons.

I.R.S. Identification Nos. of Above Persons (entities only).

 

Unitrin, Inc.

95-4255452

  2.  

Check the Appropriate Box If a Member of a Group (See Instructions)

(a)  ¨        (b)  ¨

 

  3.  

SEC Use Only

 

  4.  

Source of Funds (See Instructions)

 

    N/A

  5.  

Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)    ¨

 

  6.  

Citizenship or Place of Organization

 

    Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     7.    

Sole Voting Power –

 

    0

     8.   

Shared Voting Power –

 

    9,721,893

     9.   

Sole Dispositive Power –

 

    0

   10.   

Shared Dispositive Power –

 

    9,721,893

11.

 

Aggregate Amount Beneficially Owned by Each Reporting Person

 

    9,721,893

12.

 

Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)    ¨

 

13.

 

Percent of Class Represented by Amount in Row (11)

 

    16.1% (1)

14.

 

Type of Reporting Person (See Instructions)

 

    HC, CO

 

(1) Based on 60,241,666 shares of Common Stock outstanding as of February 11, 2011, as reported in the Form 10-K of the Issuer for the period ended December 31, 2010.


CUSIP No. 458786100

   SCHEDULE 13D/A   

Page 3 of 6

 

 

  1.   

Names of Reporting Persons.

I.R.S. Identification Nos. of Above Persons (entities only).

 

Trinity Universal Insurance Company

75-0620550

  2.  

Check the Appropriate Box If a Member of a Group (See Instructions)

(a)  ¨        (b)  ¨

 

  3.  

SEC Use Only

 

  4.  

Source of Funds (See Instructions)

 

    N/A

  5.  

Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)    ¨

 

  6.  

Citizenship or Place of Organization

 

    Texas

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     7.    

Sole Voting Power –

 

    0

     8.   

Shared Voting Power –

 

    9,721,893

     9.   

Sole Dispositive Power –

 

    0

   10.   

Shared Dispositive Power –

 

    9,721,893

11.

 

Aggregate Amount Beneficially Owned by Each Reporting Person

 

    9,721,893

12.

 

Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)    ¨

 

13.

 

Percent of Class Represented by Amount in Row (11)

 

    16.1% (1)

14.

 

Type of Reporting Person (See Instructions)

 

    IC, CO

 

(1) Based on 60,241,666 shares of Common Stock outstanding as of February 11, 2011, as reported in the Form 10-K of the Issuer for the period ended December 31, 2010.


CUSIP No. 458786100

   SCHEDULE 13D/A   

Page 4 of 6

 

Amendment No. 13 to Schedule 13D

This Amendment No. 13 amends and supplements the Schedule 13D originally filed by Unitrin, Inc. (“Unitrin”), Trinity Universal Insurance Company (“Trinity”) and United Insurance Company of America, dated November 3, 1997, as amended by Amendment No. 1, dated February 1, 2001, Amendment No. 2, dated March 15, 2001, Amendment No. 3, dated June 8, 2001, Amendment No. 4, dated July 13, 2001, Amendment No. 5, dated March 8, 2002, Amendment No. 6, dated July 9, 2002, Amendment No. 7, dated July 29, 2002, Amendment No. 8, dated March 28, 2003, Amendment No. 9, dated June 10, 2010, and Amendment No. 10, dated July 21, 2010, Amendment No. 11, dated August 23, 2010 and Amendment No. 12, dated January 24, 2011 (as amended, the “Schedule 13D”). Except as indicated in this Amendment No. 13, all other information set forth in the Schedule 13D remains unchanged and capitalized terms used herein which are not defined herein have the meanings set forth in the Schedule 13D.

 

ITEM 4. Purpose of Transaction.

Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following paragraph at the end of Item 4:

Trinity sold 682,649 shares of Common Stock in open market transactions pursuant to the Plan following January 24, 2011, the date of the last sale reported in Amendment No. 12 (the most recently filed amendment to the Schedule 13D), through April 8, 2011. The 9,721,893 shares of Common Stock beneficially owned by the filing persons as of April 8, 2011 represent approximately 16.1% of the shares of Common Stock outstanding as of February 11, 2011, as reported in the Form 10-K of the Issuer for the period ended December 31, 2010.

 

ITEM 5. Interest in Securities of the Issuer.

Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows:

As indicated on the cover pages, as of April 8, 2011, Unitrin and Trinity each beneficially own 9,721,893 shares of Common Stock over which they share voting and dispositive powers, which represent approximately 16.1% of the Common Stock outstanding as of February 11, 2011, as reported in the Form 10-K of the Issuer for the period ended December 31, 2010. Trinity sold 682,649 shares of Common Stock in open market transactions pursuant to the Plan following January 24, 2011, the date of the last sale reported in Amendment No. 12 (the most recently filed amendment to the Schedule 13D), through April 8,. The following is a listing of these sales:


CUSIP No. 458786100

   SCHEDULE 13D/A   

Page 5 of 6

 

 

Transaction Date

  

Number of Shares Sold

    

Price per Share($)*

 
01/25/11      900         11.5011   
01/26/11      23,413         11.5512   
01/27/11      25,239         11.5417   
01/28/11      3,656         11.5101   
02/01/11      46,987         11.6426   
02/02/11      56,558         11.6648   
02/03/11      15,025         11.5940   
02/16/11      10,927         11.8073   
02/17/11      16,710         11.8141   
02/18/11      24,805         11.6404   
03/22/11      5,410         10.7527   
03/23/11      40,000         10.5168   
03/24/11      42,148         10.5867   
03/25/11      34,824         10.5314   
03/28/11      24,801         10.5003   
03/29/11      40,000         10.5062   
03/30/11      40,000         10.7685   
03/31/11      40,000         10.8021   
04/01/11      37,711         10.7678   
04/04/11      35,625         10.6742   
04/05/11      29,926         10.6544   
04/06/11      37,459         10.7566   
04/07/11      35,002         10.9415   
04/08/11      15,523         10.6893   

 

* Represents the weighted average sale price per share of the shares sold on the dates specified. All sales were reported on Form 4 reports filed pursuant to Section 16 of the Securities Exchange Act of 1934. The Form 4 reports contain additional detail on the sale prices of the shares sold on each date.

Except as otherwise described in this Amendment No. 13 to Schedule 13D, to the best knowledge and belief of the filing persons: (i) during the past sixty (60) days, no filing person nor anyone listed in the Schedules to this Schedule 13D has entered into any transactions involving the Common Stock; and (ii) no one listed on the Schedules to this Schedule 13D beneficially owns shares of Common Stock.


CUSIP No. 458786100

   SCHEDULE 13D/A   

Page 6 of 6

 

SIGNATURE

After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

DATED: April 13, 2011

 

UNITRIN, INC.
By:  

/s/ JOHN BOSCHELLI

Name:   John M. Boschelli
Title:   Vice President and Chief Investment Officer
TRINITY UNIVERSAL INSURANCE COMPANY
By:  

/s/ JOHN BOSCHELLI

Name:   John M. Boschelli
Title:   Assistant Treasurer

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement; provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001).